# Effect of docetaxel administration on fluid dynamics in mice

**Authors:** Ayana Mawaki, Masushi Kohta, Aya Yoshimura, Toshio Nakatani, Shizuko Nagao, Junko Sugama

PMC · DOI: 10.20407/fmj.2024-023 · Fujita Medical Journal · 2024-12-27

## TL;DR

This study explores how docetaxel chemotherapy affects fluid movement in mice, aiming to understand and prevent fluid retention issues in cancer patients.

## Contribution

The study introduces a mouse model to investigate early-stage fluid leakage caused by docetaxel, potentially aiding in developing preventive measures for edema.

## Key findings

- Docetaxel administration increased blood plasma leakage into interstitial tissues in mice.
- Fluid transportation capacity tended to be higher in the docetaxel-treated group.
- The model could help assess plasma leakage and develop strategies to prevent edema.

## Abstract

The taxane chemotherapeutic agent docetaxel has been used as a therapy for various cancers. Some patients receiving docetaxel develop serious problems with fluid retention, which leads to peripheral edema formation, reducing the patient’s quality of life. This study investigated the effect of docetaxel administration on fluid dynamics in mice as a step toward developing advanced preventive measures in nursing.

Mice were administered 10 mg/kg/day of docetaxel intravenously for 5 days as the intervention group or with normal saline as the control group. To investigate fluid dynamics on day 5, the leakage of blood plasma, interstitial fluid volume, and fluid transportation capacity into lymph vessels were evaluated and compared between the two groups.

The Miles assay with Evans Blue, an albumin-binding dye, revealed that leakage of blood plasma was significantly increased in the control group compared with the intervention group (p<0.01). Results of the interstitial fluid volume and fluid transportation capacity were similar between the two groups, but the fluid transportation capacity tended to be higher in the intervention group.

Docetaxel administration in our mouse model caused the leakage of blood plasma without proteins from the blood vessels into the interstitial tissues, which appeared at the initial stage of edema formation. This model might be useful for assessing the leakage of blood plasma and, subsequently, the development of preventive measures against edema formation.

## Linked entities

- **Chemicals:** docetaxel (PubChem CID 148124)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}
- **Diseases:** cancers (MESH:D009369), edema (MESH:D004487), fluid (MESH:D002559)
- **Chemicals:** Evans Blue (MESH:D005070), taxane (MESH:C080625), Docetaxel (MESH:D000077143)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12040483/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12040483/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12040483/full.md

---
Source: https://tomesphere.com/paper/PMC12040483